Substance Use Disorders Practice Questions

Q: Amotivational syndrome is seen in which of the following?

Cannabis. **Explanation:** **Amotivational Syndrome** is a clinical condition characterized by apathy, lack of ambition, diminished ability to concentrate, and a loss of interest in long-term goals. It is classically associated with **chronic, heavy use of Cannabis** (specifically delta-9-tetrahydrocannabinol or THC). 1. **Why Cannabis is correct:** Chronic cannabis use is thought to affect the brain's reward system (dopaminergic pathways). Patients exhibit "cognitive dulling," social withdrawal, and a decline in school or work performance. While its status as a distinct psychiatric diagnosis is debated, it remains a high-yield association for Cannabis in medical examinations. 2. **Why the others are incorrect:** * **Cocaine & Amphetamines:** These are CNS stimulants. Chronic use typically leads to paranoia, agitation, or "crash" symptoms (depression/hypersomnia) during withdrawal, rather than a primary amotivational state. * **LSD:** As a hallucinogen, LSD is primarily associated with perceptual distortions, synesthesia, and "flashbacks" (Hallucinogen Persisting Perception Disorder), not amotivational syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Active Ingredient:** Delta-9-tetrahydrocannabinol (THC). * **Physical Sign:** Conjunctival injection (red eyes) and increased appetite ("munchies") are hallmark signs of acute intoxication. * **Psychiatric Complications:** Cannabis is a known risk factor for the precipitation of Schizophrenia in predisposed individuals. * **Flashbacks:** Though most common with LSD, they can also occur with cannabis use. * **Run Amok:** A culture-bound syndrome traditionally associated with cannabis (though also seen in other states) involving a period of brooding followed by a violent outburst.

Q: Which of the following medications is not used for alcohol detoxification?

Flumazenil. **Explanation:** The correct answer is **Flumazenil**. To answer this question correctly, it is essential to distinguish between drugs used for **alcohol withdrawal/detoxification** and those used for **relapse prevention (maintenance of abstinence)**. 1. **Why Flumazenil is the correct answer:** Flumazenil is a competitive **GABA-A receptor antagonist**. It is specifically used for the reversal of benzodiazepine overdose. It has no established role in the management of alcohol detoxification or dependence. In fact, using Flumazenil in a patient with chronic alcohol use can lower the seizure threshold, potentially precipitating withdrawal seizures. 2. **Why the other options are used in Alcohol Use Disorder:** * **Disulfiram:** An aldehyde dehydrogenase inhibitor. It causes the accumulation of acetaldehyde, leading to a highly unpleasant "disulfiram-like reaction" (nausea, flushing, tachycardia) if alcohol is consumed. It is used as **aversion therapy** for relapse prevention. * **Acamprosate:** A weak NMDA receptor antagonist and GABA-A activator. It helps reduce "protracted withdrawal" symptoms (insomnia, anxiety) and is used to maintain abstinence. * **Naltrexone:** An opioid receptor antagonist that reduces the "reward" or "high" associated with drinking by blocking endogenous opioid pathways. It reduces cravings and the risk of heavy drinking. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC) for Alcohol Withdrawal:** Benzodiazepines (e.g., Chlordiazepoxide, Diazepam). * **DOC for Withdrawal in Liver Failure:** Lorazepam, Oxazepam, Temazepam (mnemonic: **LOT**—these bypass phase I hepatic metabolism). * **Wernicke’s Encephalopathy:** Always give **Thiamine** before Glucose to prevent precipitating acute neurological deterioration.

Q: Which of the following drugs is NOT used in the treatment of heroin dependence?

Disulfiram. ### Explanation The correct answer is **A. Disulfiram**. **Why Disulfiram is the correct answer:** Disulfiram is an aldehyde dehydrogenase inhibitor used exclusively in the treatment of **Alcohol Use Disorder**, not opioid dependence. It works through **aversion therapy**; by preventing the breakdown of acetaldehyde, it causes a highly unpleasant "Disulfiram-ethanol reaction" (flushing, tachycardia, nausea) if the patient consumes alcohol. It has no pharmacological role in managing heroin (opioid) withdrawal or maintenance. **Analysis of incorrect options:** * **B. Buprenorphine:** A **partial mu-opioid agonist**. It is used for both acute detoxification and long-term maintenance therapy in heroin dependence. Its "ceiling effect" makes it safer than full agonists regarding respiratory depression. * **C. Methadone:** A **long-acting full mu-opioid agonist**. It is the gold standard for **Opioid Substitution Therapy (OST)**. It prevents withdrawal symptoms and reduces cravings without producing the intense euphoria associated with heroin. * **D. Clonidine:** An **alpha-2 adrenergic agonist**. It is used to treat the **autonomic symptoms** of opioid withdrawal (e.g., hypertension, tachycardia, sweating, diarrhea). It does not treat cravings but manages the physical distress of "cold turkey" detoxification. **High-Yield Clinical Pearls for NEET-PG:** * **Naltrexone:** An opioid antagonist used for **relapse prevention** in highly motivated patients (must be opioid-free for 7–10 days before starting). * **Lofexidine:** A newer alpha-2 agonist specifically FDA-approved for opioid withdrawal (similar to Clonidine but with less hypotension). * **Drug of Choice for Opioid Overdose:** Intravenous **Naloxone** (pure antagonist). * **Gold Standard for Maintenance:** Methadone (requires specialized clinics due to its long half-life and risk of overdose).

Q: Which of the following medications is used to maintain abstinence in alcohol dependence?

Naltrexone. ### Explanation **Correct Answer: A. Naltrexone** **Why Naltrexone is the Correct Choice:** Naltrexone is an **opioid receptor antagonist** that works by blocking the $\mu$-opioid receptors. In alcohol dependence, it reduces the "reward" or euphoric effects of drinking (the "high") and significantly decreases alcohol cravings. It is considered a first-line agent for **maintaining abstinence** and reducing the frequency of relapse. Unlike Disulfiram, it does not cause a physical reaction if alcohol is consumed, making it better tolerated for long-term use. **Analysis of Incorrect Options:** * **B. Clonidine:** This is an $\alpha_2$-agonist used primarily to manage the **autonomic symptoms of withdrawal** (tachycardia, hypertension, tremors) in opioid or alcohol withdrawal. It does not help in maintaining long-term abstinence. * **C. Disulfiram:** While used in alcohol dependence, it is an **aversive agent** (aldehyde dehydrogenase inhibitor). It causes a severe unpleasant reaction (nausea, flushing, tachycardia) if alcohol is ingested. It does not reduce craving and is generally considered second-line due to poor compliance and safety profile compared to Naltrexone. * **D. Naloxone:** This is a short-acting opioid antagonist used exclusively for the **emergency reversal of acute opioid overdose**. It has no role in the long-term maintenance of alcohol abstinence due to its short half-life and lack of oral bioavailability. **High-Yield NEET-PG Pearls:** * **Acamprosate:** Another first-line drug for abstinence; it is preferred in patients with **liver disease** (Naltrexone is hepatotoxic). * **Disulfiram Reaction:** Caused by the accumulation of **Acetaldehyde**. * **Naltrexone Requirement:** Patients must be opioid-free for 7–10 days before starting Naltrexone to avoid precipitating acute withdrawal. * **Topiramate & Baclofen:** Off-label agents used to reduce alcohol craving.

Q: An alcoholic presents with complaints of loss of memory of recent events, impaired insight, confabulation, and dementia of a few months duration. The patient is suffering from:

Korsakoff's psychosis. **Explanation:** The patient is presenting with the classic clinical triad of **Korsakoff’s Psychosis**, a chronic neuropsychiatric condition resulting from severe **Thiamine (Vitamin B1) deficiency**, typically secondary to chronic alcohol use. **Why Korsakoff’s Psychosis is correct:** Korsakoff’s is characterized by **anterograde and retrograde amnesia** (loss of recent memory), **confabulation** (filling memory gaps with fabricated stories), and lack of insight. While often preceded by Wernicke’s Encephalopathy, it is considered the chronic, irreversible stage involving damage to the **mammillary bodies** and dorsomedial nucleus of the thalamus. **Analysis of Incorrect Options:** * **A. Wernicke’s Encephalopathy:** This is the *acute* phase. It is characterized by a different triad: **Ophthalmoplegia/Nystagmus, Ataxia, and Global Confusion**. It is a medical emergency and is reversible with thiamine. * **C. Delirium Tremens:** This is a severe form of **alcohol withdrawal** occurring 48–96 hours after the last drink. It presents with autonomic hyperactivity (tachycardia, hypertension), agitation, and visual hallucinations, rather than chronic memory loss. * **D. Binswanger’s Disease:** Also known as subcortical vascular dementia, it is caused by hypertension and small vessel disease affecting white matter, unrelated to alcohol-induced thiamine deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Wernicke-Korsakoff Syndrome (WKS):** Wernicke is the acute "neurological" phase; Korsakoff is the chronic "psychiatric" phase. * **Confabulation** is the hallmark sign of Korsakoff’s; the patient is not "lying" but unconsciously compensating for memory loss. * **Management Rule:** Always administer **Thiamine before Glucose** in an alcoholic patient to prevent precipitating Wernicke’s encephalopathy. * **MRI Finding:** Atrophy of the **mammillary bodies** is a pathognomonic sign.

Q: What is the primary pharmacological treatment for opioid dependence?

Naltrexone. **Explanation:** The primary pharmacological goal in the long-term management of **Opioid Dependence** is to prevent relapse by blocking the reinforcing effects of opioids. **Why Naltrexone is correct:** Naltrexone is a long-acting **competitive opioid antagonist**. It works by binding to the mu-opioid receptors, effectively blocking the "high" if a patient uses opioids. It is used for **relapse prevention** (maintenance therapy) after the patient has been detoxified and is opioid-free for at least 7–10 days. Its long half-life makes it suitable for daily oral dosing or monthly injectable formulations. **Why other options are incorrect:** * **Naloxone:** While also an opioid antagonist, it has a very short half-life and poor oral bioavailability. It is the drug of choice for **acute opioid overdose** (emergency reversal) but is not used for the long-term treatment of dependence. * **Acamprosate:** This is a NMDA receptor modulator used specifically for the maintenance of abstinence in **Alcohol Dependence**, not opioid dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for Maintenance:** While Naltrexone is a primary antagonist treatment, **Methadone** (long-acting agonist) and **Buprenorphine** (partial agonist) are also first-line options for Opioid Substitution Therapy (OST). * **Pre-requisite:** Always perform a "Naloxone Challenge Test" before starting Naltrexone; if given while opioids are still in the system, it will precipitate **acute withdrawal syndrome**. * **Clonidine:** Often used to manage the autonomic symptoms of acute opioid withdrawal (e.g., hypertension, tachycardia). * **Pupillary signs:** Opioid overdose presents with **pinpoint pupils** (miosis), whereas withdrawal presents with **mydriasis**.

Q: In Korsakoff psychosis, which of the following is typically NOT seen?

Loss of remote memory. **Explanation:** Korsakoff Psychosis is a chronic neuropsychiatric condition resulting from a deficiency of **Thiamine (Vitamin B1)**, usually following untreated Wernicke’s Encephalopathy. The hallmark of this condition is a profound **anterograde amnesia** (inability to form new memories) and **retrograde amnesia** (loss of memories formed before the onset). **Why Option A is the correct answer:** In Korsakoff Psychosis, memory loss follows **Ribot’s Law**, which states that there is a "time gradient" in memory loss. **Recent memories are lost first**, while **remote (long-term) memories** (e.g., childhood events, basic general knowledge) are typically **preserved**. Therefore, "Loss of remote memory" is NOT a typical feature. **Analysis of Incorrect Options:** * **B. Loss of recent memory:** This is the core feature. Patients have severe impairment in acquiring new information (anterograde amnesia). * **C. Confabulation:** This is a classic compensatory mechanism where the patient fills memory gaps with fabricated, distorted, or misinterpreted stories, believing them to be true. * **D. Irreversibility:** Unlike Wernicke’s Encephalopathy (which is an acute, reversible medical emergency), Korsakoff Psychosis is a chronic stage. Only about 20% of patients show significant recovery; for most, the cognitive deficits are permanent. **NEET-PG High-Yield Pearls:** * **Brain Region Affected:** The **Dorsomedial nucleus of the Thalamus** and the **Mammillary bodies** are the primary sites of lesions. * **Wernicke’s Triad:** Ataxia, Ophthalmoplegia (6th nerve palsy), and Confusion. * **Treatment:** High-dose parenteral Thiamine. **Crucial:** Always administer Thiamine *before* Glucose to prevent precipitating Wernicke’s in a malnourished patient.

Q: Which of the following is NOT an anticraving agent for alcohol abuse?

Disulfiram. **Explanation:** The distinction between **anticraving agents** and **aversion therapy** is a high-yield concept in alcohol use disorder management. **Why Disulfiram is the correct answer:** Disulfiram is **not** an anticraving agent; it is an **aldehyde dehydrogenase inhibitor** used for **Aversion Therapy**. It works by causing the accumulation of acetaldehyde if alcohol is consumed, leading to the highly unpleasant **Disulfiram-Ethanol Reaction (DER)** (tachycardia, flushing, nausea, and palpitations). It acts as a psychological deterrent rather than reducing the physiological urge (craving) to drink. **Analysis of Incorrect Options:** * **Acamprosate (A):** An NMDA receptor antagonist and GABA-A agonist. It restores the chemical balance in the brain disrupted by chronic alcohol use and is specifically used to maintain abstinence by **reducing cravings**. * **Topiramate (C):** An antiepileptic that modulates glutamate and GABA. Clinical trials have proven its efficacy as an **off-label anticraving agent** that reduces the number of heavy drinking days. * **Naltrexone (D):** An opioid receptor antagonist. It blocks the "reward" or euphoria associated with drinking by inhibiting dopamine release in the nucleus accumbens, thereby **reducing the craving** and the "high." **NEET-PG High-Yield Pearls:** * **Acamprosate** is the drug of choice for patients with **liver disease** (excreted renally). * **Naltrexone** is contraindicated in patients with **acute hepatitis or liver failure**. * **Baclofen** is another emerging anticraving agent, particularly useful in patients with alcoholic liver disease. * **Disulfiram** requires the patient to be highly motivated and must be started only after at least 12–24 hours of abstinence.

Question 1

Amotivational syndrome is seen in which of the following?

Accepted Answer

Cannabis

Answer

Cocaine

Answer

Amphetamine

Answer

LSD

Question 2

Which of the following medications is not used for alcohol detoxification?

Accepted Answer

Flumazenil

Answer

Disulfiram

Answer

Acamprosate

Answer

Naltrexone

Question 3

Which of the following drugs is NOT used in the treatment of heroin dependence?

Accepted Answer

Disulfiram

Answer

Buprenorphine

Answer

Methadone

Answer

Clonidine

Question 4

Which of the following medications is used to maintain abstinence in alcohol dependence?

Accepted Answer

Naltrexone

Answer

Clonidine

Answer

Disulfiram

Answer

Naloxone

Question 5

An alcoholic presents with complaints of loss of memory of recent events, impaired insight, confabulation, and dementia of a few months duration. The patient is suffering from:

Accepted Answer

Korsakoff's psychosis

Answer

Wernicke's encephalopathy

Answer

Delirium tremens

Answer

Binswanger's disease

Question 6

What is the primary pharmacological treatment for opioid dependence?

Accepted Answer

Naltrexone

Answer

Naloxone

Answer

Acamprostate

Answer

All of the above

Question 7

A chronic alcoholic patient, abstinent for two days, presents with nausea, vomiting, dizziness, and generalized tonic-clonic seizures on the third day of abstinence. Which of the following is the most appropriate medication for managing these seizures?

Accepted Answer

Diazepam

Answer

Sodium valproate

Answer

Phenytoin

Answer

Carbamazepine

Question 8

In Korsakoff psychosis, which of the following is typically NOT seen?

Accepted Answer

Loss of remote memory

Answer

Loss of recent memory

Answer

Confabulation

Answer

The condition is typically irreversible

Question 9

Which of the following is NOT an anticraving agent for alcohol abuse?

Accepted Answer

Disulfiram

Answer

Acamprosate

Answer

Topiramate

Answer

Naltrexone

Question 10

Neuroadaptation to a drug is the same as which of the following?

Accepted Answer

Physical dependence

Answer

Psychological dependence

Answer

Addiction

Answer

Habituation

Substance Use Disorders — MCQs

Substance Use Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?